Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate

Clinical trial NCT06340789 · RECRUITING

Trial details

NCT number: NCT06340789
Sponsor: National Cheng-Kung University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Symptom, Cognitive Schizophrenia Schizo Affective Disorder

Start date: 2021-11-18
Primary completion: 2028-04-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.